| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | |||||||||
34,666 | 23,423 | 15,234 | 10,416 | 8,107 | 10,293 | 6,307 | 6,700 | 3,300 | 4,347 |
Cost of revenues | |||||||||
15,425 | 12,026 | 8,534 | 5,879 | 4,019 | 4,654 | 4,103 | 5,305 | 2,430 | 3,608 |
Gross profit | |||||||||
19,241 | 11,397 | 6,699 | 4,537 | 4,088 | 5,638 | 2,204 | 1,395 | 870 | 739 |
Operating expenses | |||||||||
Selling, general and administrative | |||||||||
11,656 | 7,835 | 4,055 | 2,606 | 3,734 | 2,715 | 1,476 | 760 | 547 | 548 |
Depreciation and amortization | |||||||||
- | - | 876 | 572 | 362 | 171 | 58 | 59 | 43 | - |
Depreciation and amortization | |||||||||
1,483 | 1,089 | - | - | - | - | - | - | - | 109 |
Total operating expenses | |||||||||
13,139 | 8,924 | - | - | - | - | - | - | - | - |
Total operating expenses | |||||||||
- | - | 4,932 | 3,178 | 4,096 | 2,886 | 1,534 | 820 | 591 | 657 |
Income from operations | |||||||||
6,101 | 2,472 | 1,767 | 1,358 | -8 | 2,751 | 669 | 574 | 278 | 81 |
Other income (expense) | |||||||||
Other expense | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Loss on impairment of intangibles assets | |||||||||
- | - | - | - | - | - | - | - | - | 30 |
Gain on debt extinguishment | |||||||||
- | - | - | - | 11 | 0 | - | 1,295 | 0 | 0 |
Other expense | |||||||||
0 | -31 | 16 | - | -6 | - | - | - | - | - |
Interest income | |||||||||
441 | 139 | - | - | - | - | - | - | - | - |
Interest | |||||||||
- | - | 7 | - | - | - | - | - | - | - |
Other income | |||||||||
- | - | - | 16 | - | - | - | - | - | - |
Other expenses | |||||||||
- | - | - | - | - | 0 | - | - | - | - |
Legal settlement | |||||||||
- | - | - | - | 2,500 | 0 | - | - | - | - |
Interest expense | |||||||||
- | - | - | 77 | 45 | 141 | 59 | 62 | 63 | 66 |
Total other income, net | |||||||||
441 | 108 | 23 | -60 | -2,540 | -141 | -59 | 1,233 | -63 | -97 |
Income before income tax benefit and noncontrolling interest | |||||||||
6,542 | 2,581 | 1,791 | 1,297 | -2,549 | 2,610 | 610 | 1,808 | 215 | -15 |
Income tax benefit | |||||||||
-909 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income before noncontrolling interest | |||||||||
7,452 | 2,581 | 1,785 | 1,297 | -2,549 | 2,610 | 610 | 1,808 | 215 | -15 |
Net loss attributable to the noncontrolling interest | |||||||||
-1 | -6 | -5 | -103 | -139 | -0 | -0 | -8 | - | - |
Net loss attributable to the noncontrolling interest | |||||||||
- | - | - | - | - | - | - | - | -0 | -7 |
Net income attributable to Paysign, Inc. | |||||||||
7,454 | 2,588 | 1,791 | 1,400 | -2,410 | 2,610 | 611 | 1,816 | 215 | -8 |
Net income per common share - basic | |||||||||
0.16 | 0.06 | 0.04 | 0.04 | -0.06 | 0.07 | 0.02 | 0.05 | - | 0.00 |
Net income per common share - fully diluted | |||||||||
0.14 | 0.05 | 0.04 | 0.03 | 0.00 | 0.06 | 0.01 | 0.05 | - | - |
Net income per common share - basic and fully diluted | |||||||||
- | - | - | - | - | - | - | - | 0.00 | - |
Weighted average common shares outstanding - basic | |||||||||
47,436 | 45,449 | 43,397 | 42,875 | 39,641 | 38,808 | 38,934 | 36,526 | 35,248 | 34,694 |
Weighted average common shares outstanding - fully diluted | |||||||||
54,550 | 51,986 | 48,037 | 43,867 | 0 | 42,405 | 42,394 | 39,574 | 35,248 | - |
Other [Member] | |||||||||
Revenues | |||||||||
298 | 25 | - | - | - | - | - | - | - | - |
Plasma Industry [Member] | |||||||||
Revenues | |||||||||
26,994 | 23,031 | - | - | - | - | - | - | - | - |
Pharma industry [Member] | |||||||||
Revenues | |||||||||
7,372 | 366 | - | - | - | - | - | - | - | - |